Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

Código QR

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

Tsuyoshi Otsuji,1 Kenichiro Sho,2 Akiko Tsumura,1 Naoko Koike,1 Tetsuya Nishimura,1 Kanji Takahashi2 1Department of Ophthalmology, Kansai Medical University, Takii Hospital, 2Department of Ophthalmology, Kansai Medical University, Hirakata Hospital, Osaka, Japan Background: To evaluate the effect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Otsuji T, Sho K, Tsumura A, Koike N, Nishimura T, Takahashi K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	AMD PDT Ironing PDT Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/b970113aa8934c86b8d8f8ff8f1b87d9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
por: Tvenning AO, et al.
Publicado: (2019)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
por: Koike N, et al.
Publicado: (2019)

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles
por: Hou Y, et al.
Publicado: (2020)

Malachite green-conjugated multi-walled carbon nanotubes potentiate antimicrobial photodynamic inactivation of planktonic cells and biofilms of Pseudomonas aeruginosa and Staphylococcus aureus
por: Anju VT, et al.
Publicado: (2019)

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas E, et al.
Publicado: (2017)

Photodynamic Therapy Using Toluidine Blue O (TBO) Dye as a Photosensitizer against Leishmania major
por: Mehdi Najm, et al.
Publicado: (2021)

Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy
por: Liu L, et al.
Publicado: (2018)

Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line
por: Kamel AE, et al.
Publicado: (2019)

Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging
por: Paula Loman-Cortes, et al.
Publicado: (2021)

Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy
por: Ma Z, et al.
Publicado: (2019)

Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma
por: Wang M, et al.
Publicado: (2017)

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs
por: Clement S, et al.
Publicado: (2018)

Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
por: Onyisi Christiana Didamson, et al.
Publicado: (2021)

Antimicrobial photodynamic activity and cytocompatibility of Au25(Capt)18 clusters photoexcited by blue LED light irradiation
por: Miyata S, et al.
Publicado: (2017)

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink MB, et al.
Publicado: (2016)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji T, et al.
Publicado: (2013)

Early and intermediate age-related macular degeneration: update and clinical review
por: García-Layana A, et al.
Publicado: (2017)

Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration
por: Rodriguez JD, et al.
Publicado: (2018)

Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
por: Cvetkova NP, et al.
Publicado: (2016)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
por: Varsha Pramil, et al.
Publicado: (2021)

Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
por: Hanan ElShelmani, et al.
Publicado: (2021)

Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation
por: Nadhman A, et al.
Publicado: (2016)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy B, et al.
Publicado: (2020)

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
por: Varano M, et al.
Publicado: (2016)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
por: Apsangikar P, et al.
Publicado: (2021)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
por: Cui C, et al.
Publicado: (2017)

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients
por: Jin-Ho Joo, et al.
Publicado: (2021)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
por: Razi F, et al.
Publicado: (2016)

Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL)
por: Borkenstein AF, et al.
Publicado: (2021)

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes
por: Horner F, et al.
Publicado: (2021)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
por: Canan H, et al.
Publicado: (2014)

Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
por: Hanna R, et al.
Publicado: (2021)

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
por: Negi A, et al.
Publicado: (2012)

Medication Trends for Age-Related Macular Degeneration
por: Yeon-Kyoung Cho, et al.
Publicado: (2021)

Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
por: Bek T, et al.
Publicado: (2018)

No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration
por: Schroeder M, et al.
Publicado: (2017)

Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population
por: Sarli A, et al.
Publicado: (2017)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
por: Pongsachareonnont P, et al.
Publicado: (2018)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
por: Amoaku W, et al.
Publicado: (2018)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
por: Garweg JG
Publicado: (2019)